Wockhardt USA - Our Other Websites

2009 Press Releases

September 29, 2009	Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules
July 30, 2009	Wockhardt’s Q2 Results 2009
April 24, 2009	Wockhardt’s 2008 Annual Results
February 26, 2009	Wockhardt to launch generic version of ulcer drug Ranitidine syrup in the US market
February 12, 2009	Wockhardt to launch Leveiracetam, a generic version of epilepsy drug in the US market
February 11, 2009	Wockhardt to launch Divalproex ER in the US market

December 4, 2008	Wockhardt receives US FDA approval for generic version of Augmentin* Suspension
November 13, 2008	Wockhardt launches Midazolam in the US market
October 21, 2008	Wockhardt’s Q3 Results 2008
October 16, 2008	Wockhardt gets US FDA nod to market Ceftazidime injections
July 28, 2008	Wockhardt’s Q2 Results 2008
April 28, 2008	Wockhardt’s Q1 Results 2008
February 13, 2008	Wockhardt enters the US market with generic version of Zithromax
January 9, 2008	Wockhardt to launch generic version of anti-depressant Zoloft in the US Market
January 1, 2008	Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US

October 27, 2007	Wockhardt acquires Morton Grove in the US
September 18, 2007	Wockhardt gets US FDA nod to enter the US$ 2.6 billion Norvasc market
July 09, 2007	Wockhardt to launch anti-epileptic injection, Fosphenytoin, in the US
June 20, 2007	Wockhardt to launch Cefprozil in the US
June 06, 2007	Wockhardt gets US FDA nod to enter the $680 million Lamisil market